Scientists discover llama antibodies that shut down COVID — and its future variants Date: June 16, 2025 Source: Vlaams Instituut voor Biotechnologie Summary: Powerful llama-derived antibodies ...

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 ...

Iluzanebart, a monoclonal antibody TREM2 agonist, was being developed by Vigil for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare, progressive brain disease ...

Bristol Myers Squibb’s partnership with BioNTech makes it the third big pharma company to strike a deal to gain access to a PD-L1/PD-1 and VEGF bispecific antibody with potential use in drug ...

Early screening for celiac disease (CD) in the emergency department or inpatient setting is beneficial in children with newly diagnosed type 1 diabetes mellitus (T1DM), according to results of a study ...

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies, today announced that its collaboration partn ...

Invenra Inc., a pioneer in multispecific antibody discovery and development, announces the launch of its T-Body™ trispecific antibody platform, a next-genera ...

Scientists have made a potent antivenom using antibodies from a man who has been bitten hundreds of times by venomous snakes. The therapy protects mice against the venoms of 19 species of deadly ...

A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite treatment.

Scientists identified antibodies that neutralized the poison in whole or in part from the bites of cobras, mambas and other deadly species.

Antibody-drug conjugates (ADCs), bispecific antibodies that engage T cells (BsAbs), and chimeric antigen receptor (CAR) T cells are widely used standard-of-care therapies that have revolutionized the ...